Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 0 | Phillips Ronald LEVP and CHRO | Option exercise · 10b5-1 plan | M | — 6,285 sh | Aug 12, 2026 |
| 0 | McBee BranninChief Development Officer | Derivative conversion · 10b5-1 plan | C | — 12.5K sh | Aug 12, 2026 traded Aug 10, 2026 |
| 0 | Pickering EvanGeneral Counsel | Tax withholding · 10b5-1 plan | F | $11K 54 sh | Aug 12, 2026 traded Aug 10, 2026 |
| 0 | Silbermann BenjaminDirector, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 46.9K sh | Aug 12, 2026 traded Aug 11, 2026 |
| 0 | Doyle MittieChief Medical Officer | Option exercise · 10b5-1 plan | M | $5,459 679 sh | Aug 12, 2026 traded Aug 10, 2026 |
| 0 | Walsh Mark T.Director, CEO & Director | Option exercise · 10b5-1 plan | M | $158K 50.0K sh | Aug 12, 2026 traded Aug 11, 2026 |
| 0 | Walsh Mark T.Director, CEO & Director | Option exercise · 10b5-1 plan | M | $158K 50.0K sh | Aug 12, 2026 traded Aug 10, 2026 |
| 0 | McBee BranninChief Development Officer | Derivative conversion · 10b5-1 plan | C | — 25.0K sh | Aug 12, 2026 traded Aug 10, 2026 |
| 0 | McBee BranninChief Development Officer | Derivative conversion · 10b5-1 plan | C | — 144.0K sh | Aug 12, 2026 traded Aug 10, 2026 |
| 0 | McBee BranninChief Development Officer | Derivative conversion · 10b5-1 plan | C | — 144.0K sh | Aug 12, 2026 traded Aug 10, 2026 |
| 0 | Rodman David MalcomChief Medical Officer | Option exercise · 10b5-1 plan | M | — 2,170 sh | Aug 12, 2026 traded Aug 10, 2026 |
| 0 | Silbermann BenjaminDirector, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 46.9K sh | Aug 12, 2026 traded Aug 12, 2026 |
| 0 | McBee BranninChief Development Officer | Derivative conversion · 10b5-1 plan | C | — 25.0K sh | Aug 12, 2026 traded Aug 10, 2026 |
| 0 | Pickering EvanGeneral Counsel | Tax withholding · 10b5-1 plan | F | $16K 80 sh | Aug 12, 2026 traded Aug 10, 2026 |
| 0 | Chandhok NikhilChief Product & Tech. Officer | Option exercise · 10b5-1 plan | M | — 23.3K sh | Aug 12, 2026 traded Aug 10, 2026 |
| 0 | Phillips Ronald LEVP and CHRO | Tax withholding · 10b5-1 plan | F | $80K 953 sh | Aug 12, 2026 traded Aug 10, 2026 |
| 0 | Pickering EvanGeneral Counsel | Tax withholding · 10b5-1 plan | F | $13K 64 sh | Aug 12, 2026 traded Aug 10, 2026 |
| 0 | Colburn Richard Edward IIIChief Product & Tech Officer | Option exercise · 10b5-1 plan | M | $35K 1,229 sh | Aug 12, 2026 traded Aug 10, 2026 |
| 0 | Rigler DonPrincipal Accounting Officer | Tax withholding · 10b5-1 plan | F | $12K 62 sh | Aug 12, 2026 traded Aug 10, 2026 |
| 0 | McBee BranninChief Development Officer | Derivative conversion · 10b5-1 plan | C | — 12.5K sh | Aug 12, 2026 traded Aug 10, 2026 |
| 0 | Doyle MittieChief Medical Officer | Option exercise · 10b5-1 plan | M | — 679 sh | Aug 12, 2026 traded Aug 10, 2026 |
| 55 | Jain SachinChief Operating Officer | Open-market sale | SELL | $1.25M 13.6K sh | Aug 11, 2026 traded Aug 10, 2026 |
| 53 | Bailly R JeffreyDirector, Executive Chairman | Open-market sale | SELL | $2.17M 6,866 sh | Aug 11, 2026 traded Aug 10, 2026 |
| 52 | Starrs ArtieDirector, President & CEO | Open-market purchase | BUY | $259K 10.0K sh | Aug 11, 2026 traded Aug 10, 2026 |
| 49 | Bailly R JeffreyDirector, Executive Chairman | Open-market sale | SELL | $1.82M 5,771 sh | Aug 11, 2026 traded Aug 10, 2026 |
| 47 | Bailly R JeffreyDirector, Executive Chairman | Open-market sale | SELL | $119K 374 sh | Aug 11, 2026 traded Aug 10, 2026 |
| 45 | Pridgen RobertChief Accounting Officer | Open-market sale | SELL | $306K 8,000 sh | Aug 11, 2026 traded Aug 11, 2026 |
| 45 | Maher Katherine ACVP and CAO | Open-market sale | SELL | $499K 1,062 sh | Aug 11, 2026 traded Aug 7, 2026 |
| 45 | Maher Katherine ACVP and CAO | Open-market sale | SELL | $300K 637 sh | Aug 11, 2026 traded Aug 7, 2026 |
| 44 | Zamsky MichaelChief Credit & Fin'l Risk Off. | Open-market sale | SELL | $1.19M 5,473 sh | Aug 11, 2026 traded Aug 10, 2026 |
| 43 | Jorgenrud Karl JPresident, Glob. Industrial | Open-market sale | SELL | $2.90M 7,886 sh | Aug 11, 2026 traded Aug 7, 2026 |
| 41 | Shrishrimal SumiEVP, Chief Risk Officer | Open-market sale | SELL | $670K 5,372 sh | Aug 11, 2026 traded Aug 10, 2026 |
| 41 | Patterson ChadCHIEF COMM & PRODUCT OFFICER | Open-market sale | SELL | $884K 7,093 sh | Aug 11, 2026 traded Aug 10, 2026 |
| 41 | Rosati FabioDirector | Open-market sale | SELL | $676K 7,400 sh | Aug 11, 2026 traded Aug 10, 2026 |
| 41 | Poppens JamesVice President | Open-market sale | SELL | $384K 10.0K sh | Aug 11, 2026 traded Aug 11, 2026 |
| 40 | Suzan K. DelBeneDJoint | Fort Bend Tex Indpt SCH Dist Variable 04.00000% 08/01/2054 Rate Unltd Tax BLDG Ref BDS Ser. 2024B Purchase | BUY | $250K – $500K | Aug 11, 2026 traded Jul 23, 2026 |
| 39 | Hancock William SpencerSee Remarks | Open-market sale | SELL | $2.36M 21.8K sh | Aug 11, 2026 traded Aug 7, 2026 |
| 37 | Turakhia MinangCHIEF MED/SCI OFCR EVP ADVTECH | Open-market sale | SELL | $884K 7,093 sh | Aug 11, 2026 traded Aug 10, 2026 |
| 37 | Stenberg JonDirector, President & CEO | Open-market purchase | BUY | $200K 50.0K sh | Aug 11, 2026 traded Aug 10, 2026 |
| 36 | Freeman ChrisChief Commercial Officer | Open-market sale | SELL | $6.00M 35.4K sh | Aug 11, 2026 traded Aug 10, 2026 |